Video

John DeLuca, PhD

At the 2018 CMSC Annual Meeting, Dr. DeLuca discusses the role of cognitive rehabilitation in MS.


 

Recommended Reading

VIDEO: PML prevention is possible, even when treating patients with aggressive MS
ICYMI Multiple Sclerosis
New guidelines for gadolinium-based contrast agents take conservative stance
ICYMI Multiple Sclerosis
Focus on preventing comorbidities in MS, physician urges
ICYMI Multiple Sclerosis
Global MS trends: A chaotic picture with risk as the central theme
ICYMI Multiple Sclerosis
Ocrelizumab’s Benefits on Confirmed Disability Improvement Persist in Open-Label Extension
ICYMI Multiple Sclerosis
More Frequent Dosing of Interferon Beta-1a May Benefit Patients With MS With Breakthrough Disease
ICYMI Multiple Sclerosis
Can Exercise Improve Vision in Children With MS?
ICYMI Multiple Sclerosis
Compared With Interferon, Fingolimod Improves MRI Outcomes of Pediatric MS
ICYMI Multiple Sclerosis
Cladribine Tablets Improve MRI Outcomes in Patients With Highly Active Relapsing-Remitting MS
ICYMI Multiple Sclerosis
What Are Predictors of Mortality in Veterans With MS?
ICYMI Multiple Sclerosis

Related Articles